Clinical trialNCT03198507CompletedPhase 3Interventional

ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator

SponsorRedHill Biopharma LimitedEnrollment455DyspepsiaHelicobacter Pylori Infection

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David Graham, MD
Baylor College of Medicine
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

55 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Dothan, Alabama, United States
Research Site
Phoenix, Arizona, United States
Research Site
Tucson, Arizona, United States
Research Site
North Little Rock, Arkansas, United States
Research Site
Anaheim, California, United States
Research Site
Chula Vista, California, United States
Research Site
Lomita, California, United States
Research Site
San Carlos, California, United States
Research Site
Bristol, Connecticut, United States
Research Site
Aventura, Florida, United States
Research Site
Clearwater, Florida, United States
Research Site
Coral Springs, Florida, United States
Research Site
Homestead, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Lauderdale Lakes, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Orange City, Florida, United States
Research Site
Palm Harbor, Florida, United States
Research Site
Athens, Georgia, United States
Research Site
Macon, Georgia, United States
Research Site
Marietta, Georgia, United States
Research Site
Elwood, Indiana, United States
Research Site
Metairie, Louisiana, United States
Research Site
Shreveport, Louisiana, United States
Research Site
Baltimore, Maryland, United States
Research Site
Chevy Chase, Maryland, United States
Research Site
Brockton, Massachusetts, United States
Research Site
Chesterfield, Missouri, United States
Research Site
Wyoming, Missouri, United States
Research Site
Las Vegas, Nevada, United States
Research Site
Las Vegas, Nevada, United States
Research Site
Great Neck, New York, United States
Research Site
Concord, North Carolina, United States
Research Site
Davidson, North Carolina, United States
Research Site
Fayetteville, North Carolina, United States
Research Site
Greenville, North Carolina, United States
Research Site
Tulsa, Oklahoma, United States
Research Site
Greenville, South Carolina, United States
Research Site
Sioux Falls, South Dakota, United States

15 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 18 Jun 2017
Primary completion: 24 Oct 2018
Completion: 13 Dec 2018
Last update posted: 16 Mar 2020
Registered enrollment: 455
Registry id: NCT03198507

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.